United Nations Sustainable Development Goal 6 targets access to water and sanitation for all people in the next 15 years. However, for developing countries such as Nepal, it is more challenging to achieve this goal given its poor infrastructure and high population growth. To assess the water crisis in the most developed and populated area of Nepal, the Kathmandu Valley, we estimated available water resources and domestic water demand in the valley. We estimated a supply deficit of 102 million liters per day (MLD) in 2016, after completion of the first phase of the Melamchi Water Supply Project (MWSP). If the MWSP is completed within the specified timeframe, and sufficient treatment and distribution infrastructure is developed, then there would be no water deficit by 2023–2025. This indicates that the MWSP will make a significant contribution to the valley's water security. However, emphasis must be given to utilizing all of the water available from the MWSP by developing sufficient water treatment and distribution infrastructure. Alternate mitigation options, such as planning land use for potential recharge, introducing micro- to macro-level rainwater harvesting structures, conjunctive use of surface and groundwater resources, and water demand-side management, would also be helpful.
from #Medicine via ola Kala on Inoreader http://ift.tt/1OgF2Jm
via IFTTT
Αρχειοθήκη ιστολογίου
-
▼
2023
(138)
-
▼
Φεβρουαρίου
(74)
-
▼
Φεβ 19
(9)
- Multifunctional Two-Dimensional Bi2Se3 Nanodiscs f...
- Downregulation of miR‐193a/b‐3p during HPV‐induced...
- The ability of magnetic resonance imaging to predi...
- Frequent EGFR exon 20 insertion in the so‐called p...
- Central odontogenic fibroma with amyloid: a diagno...
- Tixagevimab/Cilgavimab Treatment and Cardiovascula...
- The Ixodes ricinus salivary gland proteome during ...
- Characterization of protein-based risk signature t...
- Acute Posterior Multifocal Placoid Pigment Epithel...
-
▼
Φεβ 19
(9)
- ► Ιανουαρίου (64)
-
▼
Φεβρουαρίου
(74)
-
►
2022
(849)
- ► Δεκεμβρίου (61)
- ► Σεπτεμβρίου (74)
- ► Φεβρουαρίου (65)
-
►
2021
(2936)
- ► Δεκεμβρίου (59)
- ► Σεπτεμβρίου (180)
- ► Φεβρουαρίου (325)
-
►
2020
(1624)
- ► Δεκεμβρίου (293)
- ► Σεπτεμβρίου (234)
- ► Φεβρουαρίου (28)
-
►
2019
(13362)
- ► Δεκεμβρίου (19)
- ► Σεπτεμβρίου (54)
- ► Φεβρουαρίου (5586)
- ► Ιανουαρίου (5696)
-
►
2018
(66471)
- ► Δεκεμβρίου (5242)
- ► Σεπτεμβρίου (5478)
- ► Φεβρουαρίου (4835)
- ► Ιανουαρίου (5592)
-
►
2017
(44259)
- ► Δεκεμβρίου (5110)
- ► Σεπτεμβρίου (5105)
-
►
2016
(7467)
- ► Δεκεμβρίου (514)
- ► Σεπτεμβρίου (1038)
- ► Φεβρουαρίου (793)
Αναζήτηση αυτού του ιστολογίου
Τρίτη 10 Μαΐου 2016
Water, Vol. 8, Pages 196: The Status of Domestic Water Demand: Supply Deficit in the Kathmandu Valley, Nepal
Processes, Vol. 4, Pages 16: Process Intensification via Membrane Reactors, the DEMCAMER Project
This paper reports the findings of a FP7 project (DEMCAMER) that developed materials (catalysts and membranes) and new processes for four industrially relevant reaction processes. In this project, active, stable, and selective catalysts were developed for the reaction systems of interest and their production scaled up to kg scale (TRL5 (TRL: Technology Readiness Level)). Simultaneously, new membranes for gas separation were developed; in particular, dense supported thin palladium-based membranes for hydrogen separation from reactive mixtures. These membranes were successfully scaled up to TRL4 and used in various lab-scale reactors for water gas shift (WGS), using both packed bed and fluidized bed reactors, and Fischer-Tropsch (FTS) using packed bed reactors and in prototype reactors for WGS and FTS. Mixed ionic-electronic conducting membranes in capillary form were also developed for high temperature oxygen separation from air. These membranes can be used for both Autothermal Reforming (ATR) and Oxidative Coupling of Methane (OCM) reaction systems to increase the efficiency and the yield of the processes. The production of these membranes was scaled up to TRL3–4. The project also developed adequate sealing techniques to be able to integrate the different membranes in lab-scale and prototype reactors.
from #Medicine via ola Kala on Inoreader http://ift.tt/24JKoRD
via IFTTT
MCA, Vol. 21, Pages 17: Three-Parameter Interval Grey Number Multi-Attribute Decision Making Method Based on Information Entropy
Aimed at the situation that the plan attribute value is a three-parameter interval grey number and that attribute weight is uncertain, a three-parameter interval grey number multi-attribute decision making method based on information entropy is proposed. In this study, we combine the three-parameter interval grey number decision-making problem with information entropy, build the distance entropy model of the three-parameter interval grey number, and provide a solution to the empowerment problem of the three-parameter interval grey number in grey decision-making problems. On this basis, we build the uncertainty decision making framework based on Technique for Order Preference by Similarity to Ideal Solution (TOPSIS) thinking and obtain the comprehensive distances of plans from positive and negative ideal solutions through calculation. We thus determine the closeness, and, based on this value, organize these plans. Finally, we verify the feasibility and effectiveness of the proposed methods through case analysis.
from #Medicine via ola Kala on Inoreader http://ift.tt/1OgF2Jk
via IFTTT
Sustainability, Vol. 8, Pages 464: Towards a Model of Sustainable Competitiveness of Health Organizations
Over the last decades, around the world, the concept of competitiveness was long debated by economists (and others), widely used and even sometimes overused. Although at the theoretical level, a number of determinant factors of health care organizations' competitiveness have been proposed, their diversity and the little empirical data available argues for the need to create and validate a model of competitiveness of health organizations. The purpose of this paper is (considering the theoretical approach) to shape a model of sustainable competitiveness of health organizations. In this respect, a 51 item questionnaire was designed and applied on a sample of 291 respondents from 12 Romanian health organizations. The exploratory factor analysis undertaken recovered more than 69% of the common variability of the initial 51 variables and revealed four factors/dimensions of sustainable competitiveness of health organizations (Economic Dimension, Quality Dimension, Social Dimension, and Strategic Dimension). Among the results of the exploratory factor analysis is also the empirical evidence on the contribution of leadership and managerial processes to enhance the influence of all other factors/dimensions in increasing the sustainable competitiveness of health organizations, thus bringing into focus the concept of sustainable management and leadership. Being just in the exploratory phase of our research, the proposed model can, and should, be improved, thus opening up further research directions.
from #Medicine via ola Kala on Inoreader http://ift.tt/24JKqZJ
via IFTTT
Current and future treatment of amyloid diseases
Abstract
There are more than 30 human proteins whose aggregation appears to cause degenerative maladies referred to as amyloid diseases or amyloidoses. These disorders are named after the characteristic cross-β-sheet amyloid fibrils that accumulate systemically or are localized to specific organs. In most cases, current treatment is limited to symptomatic approaches and thus disease-modifying therapies are needed. Alzheimer's disease is a neurodegenerative disorder with extracellular amyloid β-peptide (Aβ) fibrils and intracellular tau neurofibrillary tangles as pathological hallmarks. Numerous clinical trials have been conducted with passive and active immunotherapy, and small molecules to inhibit Aβ formation and aggregation or to enhance Aβ clearance; so far such clinical trials have been unsuccessful. Novel strategies are therefore required and here we will discuss the possibility of utilizing the chaperone BRICHOS to prevent Aβ aggregation and toxicity. Type 2 diabetes mellitus is symptomatically treated with insulin. However, the underlying pathology is linked to the aggregation and progressive accumulation of islet amyloid polypeptide as fibrils and oligomers, which are cytotoxic. Several compounds have been shown to inhibit islet amyloid aggregation and cytotoxicity in vitro. Future animal studies and clinical trials have to be conducted to determine their efficacy in vivo. The transthyretin (TTR) amyloidoses are a group of systemic degenerative diseases compromising multiple organ systems, caused by TTR aggregation. Liver transplantation decreases the generation of misfolded TTR and improves the quality of life for a subgroup of this patient population. Compounds that stabilize the natively folded, nonamyloidogenic, tetrameric conformation of TTR have been developed and the drug tafamidis is available as a promising treatment.
from #Medicine via ola Kala on Inoreader http://ift.tt/1rFzvSG
via IFTTT
Precision medicine in pheochromocytoma and paraganglioma: current and future concepts
Abstract
Pheochromocytoma and paraganglioma (PPGL) are rare diseases but are also amongst the most characterized tumour types. Hence, patients with PPGL have greatly benefited from precision medicine for more than two decades. According to current molecular biology and genetics-based taxonomy, PPGL can be divided into three different clusters characterized by: Krebs cycle reprogramming with oncometabolite accumulation or depletion (group 1a); activation of the (pseudo)hypoxia signalling pathway with increased tumour cell proliferation, invasiveness and migration (group 1b); and aberrant kinase signalling causing a pro-mitogenic and anti-apoptotic state (group 2). Categorization into these clusters is highly dependent on mutation subtypes. At least 12 different syndromes with distinct genetic causes, phenotypes and outcomes have been described. Genetic screening tests have a documented benefit, as different PPGL syndromes require specific approaches for optimal diagnosis and localization of various syndrome-related tumours. Genotype-tailored treatment options, follow-up and preventive care are being investigated. Future new developments in precision medicine for PPGL will mainly focus on further identification of driver mechanisms behind both disease initiation and malignant progression. Identification of novel druggable targets and prospective validation of treatment options are eagerly awaited. To achieve these goals, we predict that collaborative large-scale studies will be needed: Pheochromocytoma may provide an example for developing precision medicine in orphan diseases that could ultimately aid in similar efforts for other rare conditions.
from #Medicine via ola Kala on Inoreader http://ift.tt/1rFzq1p
via IFTTT
Δευτέρα 9 Μαΐου 2016
Sensors, Vol. 16, Pages 659: A Precise Drunk Driving Detection Using Weighted Kernel Based on Electrocardiogram
from #Medicine via ola Kala on Inoreader http://ift.tt/1VQcNDZ
via IFTTT
-
Pharmaceutics Pharmaceutics, Vol. 12, Pages 832: Optimized Birch Bark Extract-Loaded Colloidal Dispersion Using Hydrogenated Phospholipid...
-
Vaccines Vaccines, Vol. 8, Pages 492: Anti-Flavivirus Vaccines: Review of the Present Situation and Perspectives of Subunit Vaccines Prod...
-
Cells Cells, Vol. 9, Pages 2002: Low ARID1A Expression is Associated with Poor Prognosis in Hepatocellular Carcinoma Cells, Vol. 9, Pages...